Targeted radiation & immunotherapy team up against tough cancer spread
NCT ID NCT07079462
Summary
This study is for people with colorectal cancer that has spread to the lining of the abdomen (peritoneal metastasis) and has worsened after initial treatment. It tests if using a special PET scan to guide precise abdominal radiation, combined with standard second-line therapy and an immunotherapy drug (cadonilimab), works better than standard second-line therapy alone. The main goal is to see if this new combination helps shrink tumors more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fudan University Shanghai Cancer Center
COMPLETEDShanghai, China
Conditions
Explore the condition pages connected to this study.